HeXun Biosciences Co., Ltd. (TPEX:6986)
Taiwan · Delayed Price · Currency is TWD 43.95
+0.30 (0.69%)
Jul 30, 2026, 12:49 PM CST
HeXun Biosciences Market Cap
HeXun Biosciences has a market cap or net worth of 2.02 billion as of July 29, 2026. Its market cap has decreased by -37.30% in one year.
Market Cap
2.02B
Enterprise Value
1.55B
Revenue
293.23M
Ranking
n/a
PE Ratio
18.09
Stock Price
43.95
ChartMarket Cap Chart
Since September 7, 2023, HeXun Biosciences's market cap has decreased from 4.16B to 2.02B, a decrease of -51.38%. That is a compound annual growth rate of -22.05%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 30, 2026 | 2.02B | -30.24% |
| Dec 31, 2025 | 2.90B | -6.67% |
| Dec 31, 2024 | 3.11B | 4.17% |
| Dec 29, 2023 | 2.98B | -28.32% |
| Sep 7, 2023 | 4.16B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Chunghwa Chemical Synthesis & Biotech | 2.50B |
| GlycoNex Incorporation | 2.48B |
| Syngen Biotech | 2.35B |
| Taiwan Bio Therapeutics | 2.12B |
| G&E Herbal Biotechnology | 1.93B |
| Gwo Xi Stem Cell Applied Technology Co. , | 1.89B |
| Sunhawk Vision Biotech | 1.88B |
| Sunny Pharmtech | 1.88B |